The successful transformation and widespread application of WBL’s LIPUS (Low-Intensity Pulsed Ultrasound) technology owe much to the pioneering ideas of two key figures — Academician Guo Yinglu from the Chinese Academy of Engineering and Professor Tom F. Lue from the University of California, San Francisco (UCSF). Their visionary insights paved the way for the birth of the WBL LIPUS technology. Especially in the field of urological health, Professor Lue, as a global pioneer in treating erectile dysfunction (ED), not only provided scientific theoretical support but also, through years of clinical research, transformed this concept into an actionable treatment plan, making the WBL LIPUS technology a prime example of innovation in international medical technology today.

WBL Medical: Leading Global Innovation in ED Treatment with LIPUS Technology

WBL’s LIPUS technology works by activating resident stem cells within tissues, promoting angiogenesis and nerve repair, significantly improving erectile function in ED patients. Not only does it fill the domestic technological gap, but it also provides an innovative solution for global ED treatment. This breakthrough technology is supported by deep collaboration with global urology authority Professor Tom F. Lue from UCSF. Since 2002, Professor Lue has focused on stem cells and regenerative medicine, playing a decisive scientific guiding role in the development of LIPUS technology.

As the first medical enterprise selected for the CCTV "Innovation China" program, WBL Medical not only demonstrates its achievements in scientific innovation and clinical application but has also established its influence in the global medical technology field. Currently, LIPUS technology is widely used in top-tier hospitals in 16 provinces and cities across China, benefiting millions of patients and significantly enhancing their quality of life. With numerous national honors, WBL Medical has become a core driver in the ED treatment field in China, with its technical standards widely recognized and regarded as the "gold standard" for ED treatment.

WBL has successfully promoted the “Chinese solution” for ED treatment, marking the rise of China’s independent innovation in high-end medical equipment. In the future, WBL LIPUS technology will play a larger role globally, offering safe, non-invasive, and effective treatment solutions for more ED patients.

(Front row, 4th left: Tom F. Lue)

(7th left: Tom F. Lue)

Professor Lue’s Team

Professor Tom F. Lue

Professor Tom F. Lue (MD, Honorary PhD) is a member of the American College of Surgeons. He is a professor and vice-chair of the Department of Urology at the University of California, San Francisco (UCSF). 

• He is also the Clinical Professor of Urology at the Emil Tanagho Urology Honorary Professorship and the founder and director of the Knuppe Molecular Urology Laboratory.  

• Chair of the American Urological Association’s (AUA) Global Chinese Urology Society and Permanent Member of the International Academy  

• President of the North American Society for Male Research, Chairman of the WHO Sexual Medicine International Advisory Board, and member of the Clinical Urology Advisory Committee for Nature  

• Winner of the AUA President's Award, the First Prize in Basic Research Competition, and the AUA Golden Cystoscope Award.

Professor Gui Ting Lin

Professor Gui Ting Lin is a professor of urology at the UCSF School of Medicine and vice-director of the UCSF Medical School’s Institute of Molecular Urology.  

• Secretary-General of the Global Chinese Urology Society (AUA Chapter)  

• Vice-Director of the World Chinese Male Health Association  

• Secretary-General of the China Great Wall Urology and Male Health Translational Medicine Forum’s Academic Committee

Professor Tom F. Lue: Authority in International Urology and Pioneer of LIPUS Technology

Professor Lue, as a professor in the UCSF Department of Urology and founder of the Knuppe Molecular Urology Laboratory, has been dedicated to stem cell and regenerative medicine research for many years. Since 2002, Professor Lue has made revolutionary advancements in the development of Low-Intensity Pulsed Ultrasound (LIPUS) technology. By exploring the integration of stem cells, energy medicine, and regenerative technology, Professor Lue discovered that LIPUS can stimulate dormant stem cells in human tissues through micro-energy sound waves, promoting the regeneration of blood vessels and nerves, thus effectively treating erectile dysfunction (ED). This groundbreaking discovery not only brings new hope for ED patients but also provides a new technological pathway for the global regenerative medicine field. Professor Lue’s research has made LIPUS technology a breakthrough treatment for ED, establishing his academic status and leadership in the international urology field.

Biological Mechanism of Pulsed Ultrasound Treatment for Erectile Dysfunction

Nature Urology, 2017 (Revised)

Professor Lue’s In-depth Collaboration with WBL: From Scientific Validation to Clinical Application

Professor Lue’s deep collaboration with WBL Medical marks the successful translation of LIPUS technology from theoretical research to clinical application. Through years of collaboration, Professor Lue and his team conducted extensive theoretical and innovative research, including cell and animal experiments, successfully validating the safety and efficacy of LIPUS technology in ED treatment. In these studies, Professor Lue and his team repeatedly optimized the treatment parameters of LIPUS to ensure safety and precision during the treatment process. These rigorous scientific efforts allowed LIPUS technology to break through the limitations of traditional ED treatments, becoming a benchmark in the global ED treatment field. WBL Medical, through close cooperation with Professor Lue, successfully brought this technology from the laboratory to the clinic and rapidly expanded its application in numerous countries and regions, treating tens of thousands of ED patients and promoting the internationalization of China's medical device industry.

LIPUS Ex vivo Pelvic Ganglion System - Nerve Axon Regeneration (0-72hr)(Animated Diagram)

Future: WBL LIPUS Technology Driving Global Medical Innovation

As WBL’s LIPUS technology continues to be applied in ED treatment, WBL Medical will further collaborate with top international research institutions to promote the global expansion and application of this technology. WBL LIPUS technology not only provides innovative treatment solutions for ED patients but also shows broad prospects for application in other fields. Professor Lue’s research has successfully applied LIPUS technology to the treatment of chronic diseases such as Alzheimer's and Parkinson’s diseases, opening new treatment pathways for regenerative medicine. In the future, as the technology continues to improve, WBL LIPUS will expand its scope of application to provide safer, non-invasive, and effective treatment options for patients worldwide. The collaboration between Professor Lue and WBL Medical not only drives the development of China’s medical technology but also contributes significantly to the global medical technology innovation, opening a new chapter in international medical science and technology.